Vivaldis Pimoben 1.25/2.5mg is a premium, prescription-only dual-action veterinary cardiovascular medication meticulously engineered to manage congestive heart failure (CHF) in small and toy breed dogs. This specialized tablet delivers a fixed-dose synergetic combination of two powerful cardiac agents: Pimobendan (1.25mg) and Benazepril Hydrochloride (2.5mg), precisely proportioned to allow for safe, accurate dosing in smaller canine patients.

Pimobendan functions efficiently as a positive inotrope and calcium sensitizer, enhancing the contractility of the heart muscle to increase systemic cardiac output without elevating oxygen consumption. Concurrently, Benazepril acts as a potent Angiotensin-Converting Enzyme (ACE) inhibitor, suppressing the renin-angiotensin-aldosterone system (RAAS) to dilate blood vessels, reduce arterial blood pressure, and ease peripheral resistance. Together, this multi-pronged approach minimizes cardiac workload, curtails harmful fluid retention (pulmonary edema), and curbs debilitating clinical symptoms such as chronic coughing, exercise intolerance, and heavy breathing. Administered orally on an empty stomach at strict 12-hour intervals, these palatable, easy-to-administer tablets significantly boost vitality and extend the long-term life expectancy of small dogs suffering from structural heart disease.